In addition, SGBS cells carry an FTO risk allele and the cells do not have a Simpson-Golabi-Behmel syndrome typical mutation in the glypican-3-gene (GPC3) what the name of the cell strain would suggest [47]. This evidence concerns the gene FTO and Simpson-Golabi-Behmel syndrome.